HC Wainwright Issues Negative Estimate for DRUG Earnings
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Free Report) – Research analysts at HC Wainwright decreased their Q3 2025 earnings estimates for shares of Bright Minds Biosciences in a research report issued on Wednesday, February 19th. HC Wainwright analyst P. Trucchio now anticipates that the company will earn ($0.73) per share for the quarter, down from […]
Bright Minds Biosciences Inc. (NASDAQ:DRUG – Free Report) – Research analysts at HC Wainwright decreased their Q3 2025 earnings estimates for shares of Bright Minds Biosciences in a research report issued on Wednesday, February 19th. HC Wainwright analyst P. Trucchio now anticipates that the company will earn ($0.73) per share for the quarter, down from […]
